Sai et al. [78] compared genetic variants in three candidate genes (SLCO1B1, RYR2, and GATM) and four HLA genes in 52 patients who had experienced statin-induced myopathies and 2878 healthy controls. This evidence concerns the gene SLCO1B1 and myopathy.